ArticleJAMA network open2022

Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France.

Valentin Letailleur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.